JScope
Start free trial
Home / Projects / Pharma & medical
Logistics facilityPharma & medical

Tsumura to build new quality-control facility to support stable supply

Tsumura & Co.Ami, IbarakiPublished
Investment¥7B
PhasePlanned
Start—
CompletionApr 15, 2028
To completion
Today
20272028

About 18 months to scheduled completion.

Tsumura will build a new QC building and hazardous-materials warehouse at its Ibaraki Plant in Ami, Ibaraki, to strengthen quality-testing capacity and business continuity for its kampo pharmaceutical products. Construction costs approximately ¥7 billion, designed and built by Kajima Corporation, with completion planned for mid-April 2028.

Project facts

Owner
Tsumura & Co.
Listing
4540 Tokyo
Facility
Logistics facility
Sector
Pharma & medical
Location
Ami, Ibaraki, Japan
Investment
¥7B — total
Scale / capacity
QC building 6,755.19 sqm total floor area; hazardous materials warehouse 44.80 sqm
Contractor
Kajima Corporation
Completion
Apr 15, 2028
Announced
Jul 27, 2026

Figures and schedules are as announced by the company or the public body concerned; plans can change. Amounts that were not disclosed are recorded as not disclosed, never estimated.

Also in Ibaraki7 projects · ¥77B disclosedOn the map →

Nissin Foods to build new Cup Noodles factory in TsukubamiraiNissin Foods Co., Ltd.Planned¥70BGS Yuasa to open domestic stationary energy storage system plant in IbarakiGS Yuasa CorporationPlannedn/dDai Nippon Printing opens FIO Lab manufacturing technology co-creation center in TsukubaDai Nippon Printing Co., Ltd.Plannedn/dOhishi Sangyo starts new molding machine at Ibaraki pulp-mold plantOhishi Sangyo Co., Ltd.Completedn/d

Latest in Pharma & medicalAll Pharma & medical →

Fujifilm to install ADC raw-material manufacturing equipment at Hirono plant

NewPharma & medicalFukushimaPlanned

Fujifilm will install payload and linker-payload manufacturing equipment, including reaction vessels, a filtration dryer and a preparative HPLC system, at the Hirono plant in Fukushima. The facility will also add a laboratory for process and analytical-method development, with operations scheduled to begin in 2028, enabling Fujifilm's one-stop domestic ADC CDMO service.

Shikoku Chuken to build new headquarters and research facility in Ayagawa

Pharma & medicalKagawaPlanned

Shikoku Chuken will build a new headquarters facility on land adjacent to its existing headquarters in Ayagawa, Kagawa. The facility will expand research and development using clinical specimens and testing data collected from across Shikoku, along with corporate planning, information processing and administrative functions; operations are scheduled to begin in January 2028.

Olympus completes new B Building at Nagano site for medical-device component production

Pharma & medicalNaganoCompleted¥18B

Olympus has completed the new B Building at its Nagano site in Tatsuno, Nagano, consolidating development and manufacturing functions and establishing a production base for key medical-device components. Construction began in February 2025, with full operation targeted for FY2026; the building has 17,665 sqm of total floor area and a total construction cost of approximately ¥18 billion.

JGC completes Chugai Pharma's UT3 biopharmaceutical API facility in Utsunomiya

Pharma & medicalTochigiCompleted

JGC Holdings completed the UT3 biopharmaceutical active pharmaceutical ingredient facility for Chugai Pharmaceutical Industry at its Utsunomiya plant in May 2026. The four-story facility supports clinical-trial manufacturing through initial commercial production and includes continuous-production capabilities, solar panels and other environmental features; it was handed over on May 14, 2026.